免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

藍星及藍星Rx

K 號:K230813 · 2023-07-28

申請人Welldoc, Inc.
決定日期2023-07-28
產品代碼NDC
諮詢委員會AN
決定相當於

器材摘要

BlueStar and BlueStar Rx is the device name listed in this FDA 510(k) record. The listed applicant is Welldoc, Inc.. It received FDA 510(k) clearance on 2023-07-28 under 510(k) number K230813. The device is classified under product code NDC. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the BlueStar and BlueStar Rx?

BlueStar and BlueStar Rx is a medical device that received FDA 510(k) clearance on 2023-07-28. The listed applicant is Welldoc, Inc.. The 510(k) number is K230813.

When did BlueStar and BlueStar Rx receive FDA 510(k) clearance?

BlueStar and BlueStar Rx received FDA 510(k) clearance on 2023-07-28, under 510(k) number K230813.

Who is the listed applicant for BlueStar and BlueStar Rx?

The FDA 510(k) record lists Welldoc, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BlueStar and BlueStar Rx?

The FDA product code for BlueStar and BlueStar Rx is NDC.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Welldoc, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 7 項裝置 →

相關器械(代碼:NDC)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑